KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Vir Biotechnology (VIR) Other Gross PP&E Adjustments (2018 - 2025)

Vir Biotechnology's Other Gross PP&E Adjustments history spans 8 years, with the latest figure at $25.9 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments fell 31.87% year-over-year to $25.9 million; the TTM value through Dec 2025 reached $25.9 million, down 31.87%, while the annual FY2025 figure was $25.9 million, 31.87% down from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was $25.9 million at Vir Biotechnology, down from $35.9 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $56.8 million in Q1 2024 and bottomed at -$36.7 million in Q1 2021.
  • The 5-year median for Other Gross PP&E Adjustments is $34.2 million (2024), against an average of $20.7 million.
  • The largest annual shift saw Other Gross PP&E Adjustments crashed 1024.69% in 2021 before it surged 457.58% in 2023.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at -$32.7 million in 2021, then skyrocketed by 221.79% to $39.8 million in 2022, then crashed by 40.07% to $23.9 million in 2023, then surged by 59.37% to $38.0 million in 2024, then crashed by 31.87% to $25.9 million in 2025.
  • Per Business Quant, the three most recent readings for VIR's Other Gross PP&E Adjustments are $25.9 million (Q4 2025), $35.9 million (Q3 2025), and $34.5 million (Q2 2025).